CJC-1295 (with DAC)

CJC-1295 (with DAC) is a GRF (1-29) analogue conjugated with a drug affinity complex to extend serum half-life, supplied by MyPeptides for laboratory research use only.

CJC-1295 (with DAC) is a GRF (1-29) analogue conjugated with a drug affinity complex to extend serum half-life. MyPeptides supplies it as a lyophilised 2 mg vial for in vitro laboratory research, HPLC assayed at ≥99% purity with a signed certificate of analysis on every batch.

Researchers reach for CJC-1295 (with DAC) in long-duration GH-axis research models. It is offered strictly for laboratory investigation — no personal-use claims, no dosing guidance, and no framing as a medicine.

The point of buying research grade rather than generic material is documentation. Every CJC-1295 (with DAC) order carries lot-specific HPLC and mass-spec data, so the compound in your protocol matches the compound named on the paperwork. The DAC conjugation is the point — it lengthens exposure vs the No-DAC form.